Navigation Links
Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
Date:8/3/2009

elaying the time to relapse," said Henry A. Nasrallah, M.D., a clinical investigator who worked on the INVEGA(R) SUSTENNA(TM) clinical trials, and a Professor of Psychiatry and Neuroscience and Director of the Schizophrenia Research Program at the University of Cincinnati College of Medicine. "The approval of once-monthly INVEGA(R) SUSTENNA(TM) will provide healthcare professionals with a treatment option that is, at the same time, a definitive monitoring tool for uninterrupted medication compliance, which may help optimize clinical outcomes in schizophrenia."

The approval is based on four acute symptom control studies and a longer-term maintenance study that compared INVEGA(R) SUSTENNA(TM) to placebo. INVEGA(R) SUSTENNA(TM) was superior to placebo in improving positive and negative syndrome scale (PANSS) total scores in the acute treatment trials and significantly delayed time to relapse vs. placebo in the longer-term maintenance study.

The most recent acute symptom control study was a multi-center, randomized, placebo-controlled, double-blind, parallel-group study (n=636). All patients received a dose of 234 mg on Day 1 in the deltoid muscle. From Day 8 and monthly thereafter, patients were assigned to one of three fixed doses of INVEGA(R) SUSTENNA(TM) for a period of 13 weeks. The primary endpoint of this study was the change in total PANSS score from baseline to endpoint. Each of the three additional acute treatment studies involving INVEGA(R) SUSTENNA(TM) met its primary endpoint of significantly improving PANSS scores relative to placebo.

The efficacy of INVEGA(R) SUSTENNA(TM) in maintaining symptomatic control in schizophrenia was evaluated in a multicenter, randomized, double-blind, placebo-controlled, parallel-group study (n=410). Time-to-first relapse -- the primary endpoint of the study -- was significantly longer for patients receiving INVEGA(R) SUSTENNA(TM) compared with placebo-t
'/>"/>

SOURCE Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Video: New Dove(R) Body Washes with NutriumMoisture(TM) Restore Skins Natural Moisture
2. Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology
3. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
4. Video: UCB Launches Vimpat(R) in the U.S. for Add-On Treatment of Epilepsy in Adults
5. Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)
6. Video: ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study
7. Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib
8. Video: Provectus PV-10 Interim Phase 2 Safety and Efficacy Results are as Good as or Better than Phase 1 Results
9. Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports
10. Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery
11. Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... --  Regulus Therapeutics Inc . (NASDAQ: RGLS ... development of innovative medicines targeting microRNAs, today reported ... June 30, 2015 and provided a summary of ... quarter of 2015 and recent period marked an ... Grint, M.D., President and CEO of Regulus. "Our ...
(Date:8/4/2015)... , Aug. 4, 2015 Levi & Korsinsky ... ("Biogen" or the "Company") (NASDAQGS: BIIB) for possible violations ... and certain of its officers and/or directors have violated ... of 1934.  On Friday, July 24, 2015, prior to ... quarter 2015 financial results. Among other things, the Company ...
(Date:8/4/2015)... FRANCISCO , Aug. 4, 2015  Sutro ... Nicki Vasquez , Ph.D., as vice president of ... a leadership role in the management of Sutro,s ... therapeutics pipeline, including antibody-drug conjugates, bispecific antibodies and ... Vasquez brings more than 22 years of experience ...
Breaking Medicine Technology:Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 2Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 3Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 4Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 5Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 6Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 7Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 8Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 9Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 10SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of Biogen Inc. and Its Board of Directors in Connection with Possible Violations of Federal Securities Laws -- BIIB 2Sutro Biopharma Appoints Nicki Vasquez, Ph.D. as VP of Alliance and Project Management 2
(Date:8/5/2015)... City, UT (PRWEB) , ... August 05, 2015 , ... ... “No Soda Summer” campaign by the City & County of San Francisco are ... Francisco Mayor Edwin M. Lee recently approved a measure from the City and County ...
(Date:8/5/2015)... ... August 05, 2015 , ... ... data standards. Members of global organisations such as PhUSE or CDISC are currently ... the American FDA, the Japanese PMDA and the European EMA. A move towards ...
(Date:8/4/2015)... ... ... Fla. – After completing 2,400 hours in the Clinical Pastoral Education Programs at ... Dr. Barbara Thomas-Reddick to gain the skills and the know-how in the ... staff, and she was able to witness after leaving the patients’ bedside, how “ ...
(Date:8/4/2015)... ... 2015 , ... NOVA Pride , Northern Virginia’s largest and newest LGBTQ ... identify, to join them in paving “The Road Ahead” at the second annual Northern ... October 3, 2015, from 12-9pm. In order to ensure the success of this important ...
(Date:8/4/2015)... ... ... The Journal of Pain Research has published the review “ ... Okifuji says “Both obesity and chronic pain are serious public health concerns in our ... the other. Rather, there appear to be multiple factors that contribute to each of ...
Breaking Medicine News(10 mins):Health News:HealthyYOU Vending says San Francisco’s ‘Soda Free Summer’ Initiative and Other Recent Health-related Ordinances Demonstrate Why Healthy Vending is a Growing Industry 2Health News:HealthyYOU Vending says San Francisco’s ‘Soda Free Summer’ Initiative and Other Recent Health-related Ordinances Demonstrate Why Healthy Vending is a Growing Industry 3Health News:Japan PMDA Publishes English Versions of Electronic Data Submission & Technical Conformance Guidance 2Health News:Japan PMDA Publishes English Versions of Electronic Data Submission & Technical Conformance Guidance 3Health News:New book shows how ‘The Presence of a Chaplain’ affects lives 2Health News:New book shows how ‘The Presence of a Chaplain’ affects lives 3Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 2Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 3Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 4Health News:The Association between Chronic Pain and Obesity published by Dove Medical Press 2
... ... some of the most successful businesses in America , ... Ferndale, MI (PRWEB) August 18, 2009 -- Inc. magazine recently included ... the United States. The list, based on percentage revenue growth from the last four years, ...
... ... ... 18, 2009 -- The Housekeeping Channel (HC) and the National Environmental ... necessary to help them make informed decisions to keep their homes clean and healthy. ...
... , ... Environmental Protection Agency (EPA), Antimicrobials Division lists Benefect® Disinfectant as an Antimicrobial Product Registered ... , ... August 18, 2009 -- With schools starting soon, many parents are worried that the ...
... , , ARLINGTON, Va., Aug. 18 ... verification service, and KnujO n . c om ... for Internet pharmacies. The report indicates that more than 80% of Yahoo,s Internet pharmacy ... , , In the report, the researchers state that they ...
... While video gaming is generally perceived as a pastime for ... of players in the United States is 35. Investigators from ... and Andrews University analyzed survey data from over 500 adults ... area on health risks; media use behaviors and perceptions, including ...
... , , , ... Health Plans (CDHPs) in the U.S. have surpassed HMO plans in ... (UBA) from its 2009 UBA Health Pl a ... survey with 17,655 plans from 12,316 employers reporting. , , ...
Cached Medicine News:Health News:Inc. Magazine Names Enovate as One of the Fastest-Growing Private Companies in the US. 2Health News:Inc. Magazine Names Enovate as One of the Fastest-Growing Private Companies in the US. 3Health News:NEHA - Housekeeping Channel Partnership to Improve Home Cleanliness and Health 2Health News:NEHA - Housekeeping Channel Partnership to Improve Home Cleanliness and Health 3Health News:H1N1 Flu (Swine Flu) Fears -- What People Can Do to Ease Them, According to GLT Enviro 2Health News:H1N1 Flu (Swine Flu) Fears -- What People Can Do to Ease Them, According to GLT Enviro 3Health News:Report: Yahoo! Also Displaying No-Prescription Required, non-US Internet Pharmacy Ads 2Health News:Report: Yahoo! Also Displaying No-Prescription Required, non-US Internet Pharmacy Ads 3Health News:New study finds links between video-game playing and health risks in adults 2Health News:New study finds links between video-game playing and health risks in adults 3Health News:Consumer Driven Health Plans Surpass HMOs in Popularity With Employees 2Health News:Consumer Driven Health Plans Surpass HMOs in Popularity With Employees 3Health News:Consumer Driven Health Plans Surpass HMOs in Popularity With Employees 4Health News:Consumer Driven Health Plans Surpass HMOs in Popularity With Employees 5
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: